Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.61 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.45 |
| ▸ | PDE2A | O00408 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15131117 | 0.94 | UGT2B7 (0.55) | UGT2B7MMP9CYP2D6MEN1KMT2A | |
| SCHEMBL6221889 | 0.94 | UGT2B7 (0.55) | UGT2B7MMP9CYP2D6MEN1KMT2A | |
| SCHEMBL23742756 | 0.92 | UGT2B7 (0.57) | UGT2B7MMP9CYP2D6MEN1KMT2A | |
| SCHEMBL15979349 | 0.92 | UGT2B7 (0.57) | UGT2B7MMP9CYP2D6MEN1KMT2A | |
| SCHEMBL20032327 | 0.85 | UGT2B7 (0.50) | UGT2B7MMP9CYP2D6MEN1KMT2A | |
| SCHEMBL19286311 | 0.85 | UGT2B7 (0.59) | UGT2B7MMP9CYP2D6MEN1KMT2A | |
| SCHEMBL1320202 | 0.85 | UGT2B7 (0.59) | UGT2B7MMP9CYP2D6MEN1KMT2A | |
| SCHEMBL13804034 | 0.85 | UGT2B7 (0.59) | UGT2B7MMP9CYP2D6MEN1KMT2A | |
| SCHEMBL28276305 | 0.85 | UGT2B7 (0.59) | UGT2B7MMP9CYP2D6MEN1KMT2A | |
| SCHEMBL178531 | 0.85 | UGT2B7 (0.59) | UGT2B7MMP9CYP2D6MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7884223-B2 | N-isopropylphenethylamine; N-(2,6-dimethoxybenzyl)1-phenethylamine; (R,R) N-(1-naphth-1-ylethyl)-1-phenethylamine; high activity; easily accessible | DSM IP ASSETS B.V. (NL) | 2011-02-08 | — | — | US | disclosed |
| EP-1824868-B1 | CHIRAL COMPOUND SUITABLE AS A CATALYST FOR ASYMMETRIC TRANSFER HYDROGENATION | DSM IP ASSETS BV (NL) | 2010-06-02 | — | — | EP | disclosed |
| US-20080269529-A1 | Chiral Compound Suitable as a Catalyst for Asymmetric Transfer Hydrogenation | PATHEON HOLDINGS I B.V. (NL) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269529-A1 | Chiral Compound Suitable as a Catalyst for Asymmetric Transfer Hydrogenation | SLC30A6, SLC39A14, SLC30A5 | UGT2B7 4517/4885MMP9 4105/4885CYP2D6 2453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.